Table 2. Summary of urinary proteomic biomarkers proposed for the management of pancreatic cancer.
Single biomarker or panel | Utility | Expression patterna | Impact in prognosis | Year | Ref. |
---|---|---|---|---|---|
LYVE-1, REG-1-alpha, and TFF-1 | Diagnostic | All ↑ | - | 2015 | [101] |
D-dimer | Preoperative resectability | ↑ | Negative | 2014 | [102] |
a Expression pattern observed in pancreatic cancer patients. ↑: upregulated. ↓ downregulated.